期刊文献+

异基因造血干细胞移植后重度肠道移植物抗宿主病的诊治八例报告 被引量:1

原文传递
导出
摘要 急性移植物抗宿主病(aGVHD)是异基因造血干细胞移植(allo—HSCT)的主要并发症,尤其是重度肠道GVHD,是影响移植效果的重要因素。本文回顾我院8例急性重度肠道GVHD的诊疗过程,现报告如下。
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2010年第1期55-56,共2页 Chinese Journal of Organ Transplantation
  • 相关文献

参考文献5

  • 1Ross WA, Couriel D. Colonic graft-versus-host disease. Curr Opin Gastroenlerol, 2005,21 (1) : 64-69. 被引量:1
  • 2韩伟,陆道培,黄晓军,刘开彦,陈欢,许兰平,刘代红,江倩,陈育红,路瑾,王静波,吴彤,董陆佳,任汉云.HLA配型不合造血干细胞移植GIAC方案100例临床分析[J].中华血液学杂志,2004,25(8):453-457. 被引量:68
  • 3Ponce RJ, Hackman RC, McDonald GB. Endoscopic and histologic diagnosis of intestinal graft-versus-host disease after marrow transplantation. Gastrointest Endosc, 1999, 49 ( 5 ):612-621. 被引量:1
  • 4Ferrara JL, I.evine JE. Graft-versus-hosl disease in the 21st century: new perspectives on an old problem. Semin Hematoh 2006,43(1) : 1-2. 被引量:1
  • 5Funke VA,de Medeiros CR, Set hal DC, et al. Therapy for severe refractory acute graft-versus-host disease with hasiliximab,a selective interleukin-2 receptor antagonist. Bone Marrow Transplant,2006,37(10) :961-965. 被引量:1

二级参考文献12

  • 1Kernan NA, Bartsch G, Ash RC, et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med, 1993, 328: 593-602. 被引量:1
  • 2Beatty PG. Marrow transplantation using volunteer unrelated donors in a comparison of mismatched family donor transplants:a Seattle perspective. Bone Marrow Transplant, 1994, 14 Suppl 4: S39-41. 被引量:1
  • 3Aversa F, Tabilio A, Velardi A, et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med,1998, 339: 1186-1193. 被引量:1
  • 4Mineishi S, Longo WL, Atkinson ME, et al. Addition of highdose Ara-C to the BMT conditioning regimen reduces leukemia relapse without an increase in toxicity. Bone Marrow Transplant, 1999, 23: 1217-1222. 被引量:1
  • 5Hassan HT,Stockschlader M,Schleimer B,et al. Comparison of the content and subpopulation of CD3 and CD34 positive cells in bone marrow harvest and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors. Transplant Immunol, 1996, 被引量:1
  • 6Mielcarek M, Roecklein BA, Torok-Storb B. CD14+- cells in GCSF mobilized peripheral blood mononuclear cells induce secretion of interleukin-6 and G-CSF by marrow stroma. Blood,1996, 87: 574-580. 被引量:1
  • 7Pan L, Delmonte J Jr, Jalonen CK, et al. Pretreatment of donor mice with granulocyte-colony stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood, 1995,86 : 被引量:1
  • 8Arpinati M, Loken M, Anasetti C. G-CSF mobilizes type 2-derdritic cells rather than type 1-dendritic cells. Blood, 1998, 92Suppl 1: 111a. 被引量:1
  • 9Ji SQ, Chen HR, Wang HX, et al. Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte colony-stimulating factor (lenograstim) donor-marrow priming in patients with chronic myelogenous leukemia. Biol Blood Marrow Tran 被引量:1
  • 10Ji SQ, Chen HR, Xun CQ, et al. The effect of G-CSF stimulated donor marrow on engraftment and incidence of graft-versushost disease in allogeneic bone marrow transplantation. Clin Transplant, 2001, 15: 317-323. 被引量:1

共引文献67

同被引文献11

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部